$266 Million is the total value of MONECO Advisors, LLC's 248 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RSG | REPUBLIC SVCS INC | $992,000 | +5.9% | 7,806 | 0.0% | 0.37% | +0.8% | |
QDEF | FLEXSHARES TRqlt div def idx | $466,000 | +5.7% | 8,299 | 0.0% | 0.18% | +0.6% | |
JMST | J P MORGAN EXCHANGE-TRADED Fultra sht muncpl | $421,000 | -0.5% | 8,289 | 0.0% | 0.16% | -5.4% | |
IWL | ISHARES TRrus top 200 etf | $421,000 | +4.0% | 3,929 | 0.0% | 0.16% | -1.2% | |
RWL | INVESCO EXCH TRADED FD TR IIs&p 500 revenue | $377,000 | +8.6% | 4,772 | 0.0% | 0.14% | +3.6% | |
BBEU | J P MORGAN EXCHANGE-TRADED Fbetabuilders eur | $349,000 | +1.5% | 6,026 | 0.0% | 0.13% | -3.7% | |
SEDG | SOLAREDGE TECHNOLOGIES INC | $347,000 | -12.8% | 1,500 | 0.0% | 0.13% | -17.2% | |
IUSG | ISHARES TRcore s&p us gwt | $327,000 | +1.2% | 3,153 | 0.0% | 0.12% | -3.1% | |
KKR | KKR & CO INC | $288,000 | +16.6% | 4,055 | 0.0% | 0.11% | +11.3% | |
ETY | EATON VANCE TAX-MANAGED DIVE | $270,000 | +1.1% | 19,132 | 0.0% | 0.10% | -3.8% | |
BBCA | J P MORGAN EXCHANGE-TRADED Fbetabuilders cda | $264,000 | +6.0% | 3,961 | 0.0% | 0.10% | +1.0% | |
EFA | ISHARES TRmsci eafe etf | $257,000 | -2.7% | 3,389 | 0.0% | 0.10% | -6.7% | |
VGSH | VANGUARD SCOTTSDALE FDSshort term treas | $242,000 | -1.6% | 4,006 | 0.0% | 0.09% | -6.2% | |
HTA | HEALTHCARE TR AMER INCcl a new | $241,000 | +8.6% | 7,500 | 0.0% | 0.09% | +3.4% | |
SCHB | SCHWAB STRATEGIC TRus brd mkt etf | $224,000 | +0.9% | 2,133 | 0.0% | 0.08% | -4.5% | |
PGX | INVESCO EXCH TRADED FD TR IIpfd etf | $168,000 | -5.6% | 11,821 | 0.0% | 0.06% | -10.0% | |
PFN | PIMCO INCOME STRATEGY FD II | $92,000 | -8.9% | 10,000 | 0.0% | 0.04% | -12.5% | |
UEC | URANIUM ENERGY CORP | $26,000 | -16.1% | 10,000 | 0.0% | 0.01% | -16.7% | |
CIF | MFS INTER HIGH INCOME FDsh ben int | $25,000 | -21.9% | 10,630 | 0.0% | 0.01% | -30.8% | |
MTNB | MATINAS BIOPHARMA HLDGS INC | $22,000 | -43.6% | 30,000 | 0.0% | 0.01% | -46.7% | |
BIOL | BIOLASE INC | $11,000 | -42.1% | 30,000 | 0.0% | 0.00% | -42.9% | |
IDEX | IDEANOMICS INC | $10,000 | -50.0% | 10,310 | 0.0% | 0.00% | -50.0% | |
TONIX PHARMACEUTICALS HLDG C | $7,000 | -66.7% | 35,000 | 0.0% | 0.00% | -62.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-08
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD INDEX FDS | 20 | Q3 2023 | 8.8% |
ISHARES TR | 20 | Q3 2023 | 8.5% |
APPLE INC | 20 | Q3 2023 | 5.9% |
SPDR SER TR | 20 | Q3 2023 | 4.8% |
ISHARES TR | 20 | Q3 2023 | 4.1% |
GOLDMAN SACHS ETF TR | 20 | Q3 2023 | 4.9% |
JOHNSON & JOHNSON | 20 | Q3 2023 | 4.2% |
NUVEEN S&P 500 BUY-WRITE INC | 20 | Q3 2023 | 4.0% |
MICROSOFT CORP | 20 | Q3 2023 | 2.6% |
SPDR S&P 500 ETF TR | 20 | Q3 2023 | 3.9% |
View MONECO Advisors, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-25 |
13F-HR/A | 2024-03-13 |
13F-HR/A | 2024-03-13 |
13F-HR/A | 2024-03-13 |
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-03 |
13F-HR | 2023-05-12 |
13F-HR | 2023-01-30 |
13F-HR | 2022-11-02 |
View MONECO Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.